Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Allergol Immunopathol (Madr) ; 40(6): 357-61, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22115572

RESUMO

BACKGROUND: Traditional medicines and health supplements have historically been used to treat many illnesses but most of them have not been evaluated objectively to prove their efficacy. We have been investigating the effects of royal jelly (RJ) supplements on acetic acid-induced colitis on the distribution of CD3(+), CD5(+), CD45(+) T-cell and CD68(+) cells in rats. METHODS: The rats were divided into four equal groups: control group, royal jelly-treated (RJ - 150mgkg(-1) body weight), acetic acid-treated (colitis) and acetic acid-treated (colitis)+royal jelly (CRJ - 150mgkg(-1) body weight). Colitis was induced by intracolonic instillation of 4% acetic acid; the control group received physiological saline (10mLkg(-1)). Colon samples were obtained under deep anaesthesia from animals in four groups. Tissues were fixed in 10% formalin neutral buffer solution for 24h and embedded in paraffin. RESULTS: The proliferative response of CD3(+) and CD45(+) T cells stimulated with colitis was affected by colitis treated with RJ. No differences were found in CD5(+) T cells and CD68(+) macrophages in the colitis treated with RJ. CONCLUSIONS: This study has shown that RJ has anti-inflammatory and cell regeneration effect in the colon of rats with acetic acid induced colitis.


Assuntos
Anti-Inflamatórios/administração & dosagem , Colite/tratamento farmacológico , Colite/imunologia , Colo/imunologia , Ácidos Graxos/administração & dosagem , Linfócitos T/efeitos dos fármacos , Ácido Acético/farmacologia , Animais , Antígenos CD/análise , Antígenos de Diferenciação Mielomonocítica/análise , Complexo CD3/análise , Antígenos CD5/análise , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Colite/induzido quimicamente , Humanos , Antígenos Comuns de Leucócito/análise , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Ratos , Ratos Endogâmicos BB , Linfócitos T/imunologia
2.
Mod Pathol ; 18(8): 1121-6, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15803190

RESUMO

We report the clinicopathological features of two cases of intravascular large B-cell lymphoma involving cutaneous hemangiomas. The cases were identified from the consultation files of two of the authors. Both patients were women, 64 and 55 years of age, who presented with long-standing cutaneous hemangiomas of the posterior scalp and left shoulder, respectively. The lesions were brought to medical attention by an increase in size and change in color. Biopsies and immunohistochemical evaluation of the hemangiomas revealed extensive involvement by intravascular large B-cell lymphoma. The neoplastic cells were diffusely positive for CD20 in both cases and negative for CD3, pan-cytokeratin (AE1/AE3), epithelial membrane antigen, S-100, Factor VIII-related antigen, CD34 and CD31. Disease was limited to the hemangiomas in both patients. Treatment consisted of chemotherapy (both patients) and adjuvant radiation therapy (one patient). One patient had a recurrence of disease 33 months after initial diagnosis, leading to an autologous stem cell transplant. The other patient is without evidence of disease 27 months after initial diagnosis. Although this is a rare neoplasm, it is important to consider intravascular large B-cell lymphoma in the differential diagnosis of vascular lesions containing intravascular neoplastic cells.


Assuntos
Hemangioma/patologia , Linfoma de Células B/patologia , Linfoma Difuso de Grandes Células B/patologia , Neoplasias Vasculares/patologia , Antígenos CD19/análise , Antígenos CD20/análise , Antígenos CD5/análise , Proteínas de Ligação a DNA/análise , Diagnóstico Diferencial , Feminino , Hemangioma/metabolismo , Hemangioma/terapia , Humanos , Imuno-Histoquímica , Fatores Reguladores de Interferon , Antígenos Comuns de Leucócito/análise , Linfoma de Células B/metabolismo , Linfoma de Células B/terapia , Linfoma Difuso de Grandes Células B/metabolismo , Linfoma Difuso de Grandes Células B/terapia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Proteínas Proto-Oncogênicas/análise , Proteínas Proto-Oncogênicas c-bcl-6 , Fatores de Transcrição/análise , Neoplasias Vasculares/metabolismo , Neoplasias Vasculares/terapia
3.
J Neuroimmunol ; 104(1): 37-46, 2000 Apr 03.
Artigo em Inglês | MEDLINE | ID: mdl-10683513

RESUMO

The direct and indirect interaction between the nervous system and its transmitters with the immune system was evaluated in the rat by using the neurotoxin capsaicin (Caps). In the present study we investigated the effect of Caps administration to neonatal rats on thymocyte subpopulation distribution and functions at different times after treatment. Caps treatment results in a marked reduction of thymus weight and cellularity. As shown by immunofluorescence and FACS analysis, profound depletion of double negative (DN), double positive (DP), and single positive (SP) CD4(+) cells was already evident at day 7 after treatment and persisted until day 28. Reduced numbers of SP CD8(+) cells were observed only at later time points. Analysis of TCR phenotype indicates that CD5(+) TCR gamma/delta(+) are particularly sensitive to neonatal Caps treatment. Caps-induced thymocyte depletion was associated with reduced proliferation in response to T cell mitogens. Moreover, in situ TUNEL reaction and agarose gel electrophoresis indicate that neonatal Caps treatment induces apoptosis of thymus cells. Morphological analysis reveals the presence of apoptotic cells in the subcapsular thymus cortical region. Overall our results suggest that Caps when administered at birth, profoundly affects T cell differentiation, likely through its ability to activate apoptotic cell death program.


Assuntos
Timo/citologia , Animais , Animais Recém-Nascidos/fisiologia , Apoptose , Antígenos CD4/análise , Antígenos CD5/análise , Antígenos CD8/análise , Capsaicina/farmacologia , Diferenciação Celular , Divisão Celular/efeitos dos fármacos , Feminino , Masculino , Mitógenos/farmacologia , Ratos , Ratos Wistar , Receptores de Antígenos de Linfócitos T alfa-beta/metabolismo , Receptores de Antígenos de Linfócitos T gama-delta/metabolismo , Timo/efeitos dos fármacos , Timo/imunologia , Timo/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA